According to the publisher, the digital PCR market is expected to grow at a compound annual growth rate (CAGR) of 10% from 2024 to 2031, reaching $182.33 million in 2024 and $354.58 million by the end of 2031. The market's expansion is fueled by strong demand for innovative diagnostic procedures and significant advancements in PCR technology.
The digital PCR (dPCR) technology has revolutionized molecular biology by enabling ultrasensitive and repeatable detection and quantification of nucleic acids. Since its initial proposal by Sykes et al. in 1992 and further development by Kalinina et al. in 1997, dPCR has continuously evolved. Innovations such as the Droplet dPCR SARS-CoV-2 Test Kit and the Xpert Xpress SARS-CoV-2 test have significantly contributed to market growth, particularly during the COVID-19 pandemic.
2. Increasing Demand for Diagnostic Tools
The demand for cutting-edge diagnostic tools and therapies is rising due to the increasing incidence of infectious diseases and cancer globally. Digital PCR is widely used in molecular genetic analysis, cancer detection, mutational analysis, and quantitative gene expression studies, making it an indispensable tool in modern diagnostics.
3. Expanding Applications in Various Fields
Digital PCR has broad applications beyond healthcare, including environmental testing, food safety, animal health, and forensic science. The technology's ability to provide accurate results in minimal time with high sensitivity and specificity has driven its adoption in these fields.
This product will be delivered within 1-3 business days.
Key Market Drivers
1. Technological Advancements in PCRThe digital PCR (dPCR) technology has revolutionized molecular biology by enabling ultrasensitive and repeatable detection and quantification of nucleic acids. Since its initial proposal by Sykes et al. in 1992 and further development by Kalinina et al. in 1997, dPCR has continuously evolved. Innovations such as the Droplet dPCR SARS-CoV-2 Test Kit and the Xpert Xpress SARS-CoV-2 test have significantly contributed to market growth, particularly during the COVID-19 pandemic.
2. Increasing Demand for Diagnostic Tools
The demand for cutting-edge diagnostic tools and therapies is rising due to the increasing incidence of infectious diseases and cancer globally. Digital PCR is widely used in molecular genetic analysis, cancer detection, mutational analysis, and quantitative gene expression studies, making it an indispensable tool in modern diagnostics.
3. Expanding Applications in Various Fields
Digital PCR has broad applications beyond healthcare, including environmental testing, food safety, animal health, and forensic science. The technology's ability to provide accurate results in minimal time with high sensitivity and specificity has driven its adoption in these fields.
Market Dynamics and Insights
Sales Analysis and Market Outlook
The market's growth rate is expected to accelerate in the coming years, with significant contributions from the development of new PCR-based consumables and reagents.Regional Insights
United States:
The United States accounted for a significant 23.9% share of the global digital PCR market in 2022. This substantial market share is driven by the presence of major pharmaceutical and biotechnology companies, which are at the forefront of innovation and development. High investments in research and development (R&D) further fuel market growth, as these companies continuously strive to develop advanced diagnostic tools and therapies. Additionally, the U.S. benefits from a well-established healthcare infrastructure and strong support from both public and private sectors for genome analysis and related research. The country's robust academic and research institutions also contribute to the widespread adoption of digital PCR technologies, enhancing the market's expansion.China:
China held a market share of 5.7% in the global digital PCR market in 2022. The surge in demand for PCR tests during the COVID-19 pandemic played a crucial role in boosting the market. China's rapid response to the pandemic included extensive testing and deployment of advanced PCR technologies to manage and control the virus spread. The government's support for R&D in the healthcare sector and the increasing focus on precision medicine and molecular diagnostics have further propelled the digital PCR market. Additionally, the country's efforts to enhance its healthcare infrastructure and the growing number of biotechnology startups are expected to drive continued market growth in the coming years.Germany:
Germany commanded a dominant 24.1% share of the European digital PCR market in 2022, reflecting its strong position in the region. The country's robust R&D infrastructure and extensive collaboration agreements within the pharmaceutical sector are key growth drivers. Germany is known for its cutting-edge research facilities and significant investments in the life sciences, which foster innovation and the development of advanced diagnostic technologies. The country's emphasis on precision medicine, genetic research, and the integration of digital PCR in clinical and research applications contribute to its leading market position. Additionally, Germany's strategic partnerships with global biotech companies and its support for startup ecosystems create a conducive environment for the growth of the digital PCR market.Category-wise Insights
Product Segment
- Instruments: Instruments held the largest share of the market in 2022, accounting for over 70%. This segment is expected to continue its dominance due to the user-friendly nature and high demand for digital PCR tools in research applications.
End Users
- Research Institutes: Research institutes dominated the end-user segment in 2022, with a 70% market share. The increasing demand for developing novel products and understanding disease mechanisms has led to a surge in research activities using PCR technology.
Competitive Analysis
Key players in the digital PCR market are focusing on expanding their product portfolios and obtaining regulatory approvals to strengthen their market presence. Notable developments include:
- Bio-Rad Laboratories, Inc.: Received approval from the US FDA for its QXDX AutoDG digital PCR System and the QXDX BCR-ABL %IS Kit.
- Thermo Fisher Scientific: Unveiled a new capillary electrophoresis (CE) system for Sanger sequencing and fragment analysis.
- Fluidigm Corporation: Entered into a licensing agreement with Baylor Genetics to provide NGS library prep assays for research using the Juno System.
Key Market Players Include
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Fluidigm Corp.
- Formulatrix, Inc.
- JN Medsys.
- STILLA TECHNOLOGIES
- Avance Bioscience
- Fluidgm corporation,
- jn medsys
- Merck KGAA
- Precigenome LLC
- QIAGEN N.V
- Sysmex corporation.
Key Segments of the Digital PCR Industry
By Product:
- Instrument
- Consumables
- Services
By End User:
- Pharmaceutical Companies
- Research Institutes
- Forensic Labs
- Agriculture Companies
By Application:
- Clinical Diagnostics
- Basic Research
- Applied Research
- Forensic Testing
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East & Africa
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Market Overview
3. Price Analysis, 2018 - 2024
4. Global Digital PCR Market Outlook, 2018 - 2031
5. North America Digital PCR Market Outlook, 2018 - 2031
6. Europe Digital PCR Market Outlook, 2018 - 2031
7. Asia Pacific Digital PCR Market Outlook, 2018 - 2031
8. Latin America Digital PCR Market Outlook, 2018 - 2031
9. Middle East & Africa Digital PCR Market Outlook, 2018 - 2031
10. Competitive Landscape
11. Appendix
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- Fluidigm Corp.
- Formulatrix, Inc.
- JN Medsys.
- STILLA TECHNOLOGIES
- Avance Bioscience
- Fluidgm corporation,
- jn medsys
- Merck KGAA
- Precigenome LLC
- QIAGEN N.V
- Sysmex corporation.
Methodology
LOADING...
